Female Health ROA 2006-2019 | VERU

Current and historical return on assets (ROA) values for Female Health (VERU) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Female Health ROA for the three months ending December 31, 2019 was -24.74%.
Female Health ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-12-31 $-0.01B $0.06B -24.30%
2019-09-30 $-0.01B $0.05B -22.75%
2019-06-30 $-0.02B $0.05B -33.17%
2019-03-31 $-0.02B $0.05B -43.14%
2018-12-31 $-0.02B $0.05B -41.71%
2018-09-30 $-0.02B $0.05B -45.71%
2018-06-30 $-0.02B $0.05B -38.71%
2018-03-31 $-0.01B $0.06B -25.34%
2017-12-31 $-0.01B $0.05B -21.82%
2017-09-30 $-0.01B $0.06B -15.65%
2017-06-30 $-0.01B $0.06B -11.21%
2017-03-31 $-0.00B $0.06B -8.08%
2016-12-31 $-0.00B $0.06B -4.42%
2016-09-30 $0.00B $0.04B 0.00%
2016-06-30 $0.00B $0.04B 7.64%
2016-03-31 $0.00B $0.04B 7.84%
2015-12-31 $0.01B $0.04B 13.42%
2015-09-30 $0.01B $0.04B 13.99%
2015-06-30 $0.00B $0.04B 8.70%
2015-03-31 $0.00B $0.04B 8.96%
2014-12-31 $0.00B $0.03B 3.05%
2014-09-30 $0.00B $0.03B 3.01%
2014-06-30 $0.01B $0.03B 26.47%
2014-03-31 $0.01B $0.03B 26.67%
2013-12-31 $0.01B $0.04B 35.56%
2013-09-30 $0.02B $0.04B 46.15%
2013-06-30 $0.02B $0.03B 51.20%
2013-03-31 $0.02B $0.03B 61.02%
2012-12-31 $0.02B $0.03B 62.96%
2012-09-30 $0.02B $0.03B 64.65%
2012-06-30 $0.01B $0.03B 59.09%
2012-03-31 $0.01B $0.02B 51.28%
2011-12-31 $0.01B $0.02B 45.07%
2011-09-30 $0.01B $0.02B 29.85%
2011-06-30 $0.01B $0.02B 36.36%
2011-03-31 $0.01B $0.02B 36.92%
2010-12-31 $0.01B $0.02B 49.23%
2010-09-30 $0.01B $0.02B 44.44%
2010-06-30 $0.00B $0.01B 18.75%
2010-03-31 $0.00B $0.02B 24.62%
2009-12-31 $0.00B $0.02B 25.81%
2009-09-30 $0.01B $0.02B 47.46%
2009-06-30 $0.01B $0.02B 51.85%
2009-03-31 $0.01B $0.01B 53.85%
2008-12-31 $0.01B $0.01B 46.15%
2008-09-30 $0.01B $0.01B 37.74%
2008-06-30 $0.00B $0.01B 32.00%
2008-03-31 $0.00B $0.01B 26.09%
2007-12-31 $0.00B $0.01B 19.05%
2007-09-30 $0.00B $0.01B 10.81%
2007-06-30 $0.00B $0.01B 0.00%
2007-03-31 $0.00B $0.01B 0.00%
2006-12-31 $0.00B $0.01B 0.00%
2006-09-30 $0.00B $0.01B 0.00%
2006-06-30 $0.00B $0.01B 0.00%
2006-03-31 $0.00B $0.01B 0.00%
2005-12-31 $0.00B $0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.276B $0.032B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $158.029B 27.58
Medtronic (MDT) Ireland $152.495B 20.50
Stryker (SYK) United States $84.317B 27.25
Boston Scientific (BSX) United States $59.962B 27.06
Baxter (BAX) United States $47.563B 28.84
EssilorLuxottica Societe Anonyme (ESLOY) France $33.669B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.914B 20.33
Lonza Group Ag (LZAGY) Switzerland $31.999B 0.00
Coloplast (CLPBY) Denmark $30.931B 47.73
Terumo (TRUMY) Japan $26.401B 32.95
ResMed (RMD) United States $25.542B 44.38
Smith & Nephew SNATS (SNN) United Kingdom $21.089B 0.00
Sunny Optical Technology (SNPTF) China $18.226B 0.00
Insulet (PODD) United States $13.333B 634.32
Bio-Rad Laboratories (BIO) United States $12.243B 57.20
Perrigo (PRGO) Ireland $8.058B 15.02
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Canopy Growth (CGC) Canada $7.606B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Hill-Rom Holdings (HRC) United States $7.276B 20.93
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.058B 37.29
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.488B 0.00
ICU Medical (ICUI) United States $4.469B 29.13
NuVasive (NUVA) United States $4.132B 32.54
GW Pharmaceuticals (GWPH) United Kingdom $3.908B 0.00
Neogen (NEOG) United States $3.835B 63.82
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.660B 0.00
Quidel (QDEL) United States $3.444B 30.24
Agios Pharmaceuticals (AGIO) United States $3.123B 0.00
National Vision Holdings (EYE) United States $2.810B 63.43
Aurora Cannabis (ACB) Canada $1.999B 0.00
AtriCure (ATRC) United States $1.668B 0.00
TG Therapeutics (TGTX) United States $1.592B 0.00
Cardiovascular Systems (CSII) United States $1.556B 0.00
InMode (INMD) Israel $1.249B 0.00
NanoString Technologies (NSTG) United States $1.207B 0.00
Aphria (APHA) $1.129B 0.00
Phibro Animal Health (PAHC) United States $1.055B 20.86
VAREX IMAGING (VREX) United States $0.998B 20.74
PetIQ (PETQ) United States $0.983B 23.99
Cerus (CERS) United States $0.828B 0.00
Quanterix (QTRX) United States $0.805B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.723B 27.68
Omeros (OMER) United States $0.669B 0.00
Lantheus Holdings (LNTH) United States $0.649B 16.21
LeMaitre Vascular (LMAT) United States $0.613B 34.83
MacroGenics (MGNX) United States $0.531B 0.00
Surmodics (SRDX) United States $0.513B 58.99
OraSure Technologies (OSUR) United States $0.439B 54.77
Organigram Holdings (OGI) Canada $0.433B 0.00
Owens & Minor (OMI) United States $0.423B 15.65
HEXO (HEXO) $0.409B 0.00
Utah Medical Products (UTMD) United States $0.356B 25.29
Meridian Bioscience (VIVO) United States $0.348B 14.02
Zynex (ZYXI) United States $0.344B 38.89
BioLife Solutions (BLFS) United States $0.334B 136.00
Repro-Med Systems (KRMD) United States $0.280B 0.00
Bovie Medical (APYX) United States $0.260B 0.00
InfuSystems Holdings (INFU) United States $0.233B 1175.00
Viemed Healthcare (VMD) United States $0.217B 22.92
Vapotherm (VAPO) United States $0.212B 0.00
United Health Products (UEEC) United States $0.192B 0.00
Cytosorbents (CTSO) United States $0.189B 0.00
Rockwell Medical (RMTI) United States $0.189B 0.00
Liberty Health Sciences (LHSIF) Canada $0.176B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.159B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.132B 0.00
Fonar (FONR) United States $0.130B 9.48
Chimerix (CMRX) United States $0.106B 0.00
Surface Oncology (SURF) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MRI Interventions (CLPT) United States $0.088B 0.00
United-Guardian (UG) United States $0.080B 20.35
MTech Acquisition (KERN) United States $0.076B 0.00
Nephros (NEPH) United States $0.072B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
FSD PHARMA INC (HUGE) Canada $0.045B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
NF Energy Saving (BIMI) China $0.031B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.007B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Myomo (MYO) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Valeritas Holdings (VLRX) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00